Hemopericardium and Cardiac Tamponade in a Patient Treated with Dabigatran Etexilate

Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports of hemopericardium are rare. We described a case of a 66 year-old female pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kızılırmak, Filiz, Gunes, Haci Murat, Guler, Ekrem, Demir, Gultekin Gunhan, Karaca, Oguz, Canpolat, Habibe Gamze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720855/
https://www.ncbi.nlm.nih.gov/pubmed/26798391
http://dx.doi.org/10.4070/kcj.2016.46.1.99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720855/
https://www.ncbi.nlm.nih.gov/pubmed/26798391
http://dx.doi.org/10.4070/kcj.2016.46.1.99

Ejemplares similares